Engage in a dynamic panel discussion featuring renowned experts, moderated by Dr. Rucha Mehta, as they deliberate on the ongoing relevance of Metformin as the first-line treatment for Type 2 Diabetes Mellitus (T2DM). Diabetes management has recently become more outcomes-focused, shifting from concentrating exclusively on glycemic control to considering the impact these medications have on complications from Diabetes. In this session, these esteemed experts will weigh the pros and cons, exploring the evolving landscape of T2DM management and potential alternatives to Metformin. Join us for an enlightening conversation that addresses the critical question of whether Metformin remains the primary choice in T2DM therapy.

Panel: Is Metformin still the first choice of T2DM?

Consultant Endocrinologist and PhysicianMumbai

Dr. Shashank Joshi

-

-

-

-

Sessions Taken

815

5